Medical Newspaper Mobile Site, Binex Year 15 Pharmaceutical Companies · 18 Items’Temporary Salary Suspension’

[의학신문·일간보사=이승덕 기자]Following Binex, 18 items from 15 pharmaceutical companies were temporarily suspended.

These are items that are covered by salary among 32 items entrusted and manufactured in the same way as Binex.

On the 9th, the Ministry of Health and Welfare announced such measures through the’information on the suspension of insurance drug benefits.

On the 8th, Binex manufactured synthetic drugs differently from those reported on the previous 8th, and received measures from the Ministry of Food and Drug Safety and the Ministry of Welfare to temporarily suspend manufacturing and sales, respectively.

This measure is also a follow-up measure following the temporary suspension of manufacturing and sales by the Ministry of Food and Drug Safety. And decided to discontinue use.

Accordingly, the Ministry of Health and Welfare has temporarily suspended and guided the drug payments for 18 drugs that are covered by health insurance benefits from the medical treatment on March 9.

Looking at the 18 drugs covered, there are four dexibropene-based products, such as △Dicarol tablet (Ildong Pharmaceutical), △Exifen tablet (Hanall Biopharma), △Sonyfen tablet 300mg (JW new drug) △Deckfen tablet (Alarm Pharmaceutical).

Fluoxetine hydrochloride component products include △Unizak Capsule 10mg (Unimed Pharmaceuticals) △Unizak Capsule 20mg (Unimed Pharmaceuticals) △Slicetin Capsule 10mg (Dongkuk Pharmaceutical) △Slicetin Capsule (Dongkuk Pharmaceutical) △Wellfit Capsule 10mg (WooriDul Pharmaceutical) ), and the component of fluoxetine hydrochloride is △ Wellfit Capsule (Woorideul Pharmaceutical).

The glimepiride component products are △Gril tablet (SPC) △Gluvi tablet (Alvogen Korea), and the ciprofloxacin hydrochloride hydrate product is △Punglim Ciprofloxacin Hydrochloride Hydrate Hydrate (Pungrim Muek) △Nuroxacin Tablet (Guju Pharmaceutical) △Siloxin Tablet 250mg Jinyang Pharmaceutical) △Ciflon Tablet 250mg (Hana Pharmaceutical), △Siroctan Tablet 250mg (I-Cure) △Cifloc Q Tablet 250mg (Cho-A Pharmaceutical).

The Ministry of Health and Welfare also took measures to allow claims for medical treatment on March 9, which inevitably occurred due to prescriptions and dispensing before notification of the suspension of pay.

Source